Nouress
NDC 76014-006
Product Information
Nouress is a NDA-approved product labeled by Avadel Legacy Pharmaceuticals, Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 76014-006 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 76014-006?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CYSTEINE HYDROCHLORIDE (UNII: ZT934N0X4W)
- CYSTEINE (UNII: K848JZ4886) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1667993 - cysteine HCl 0.5 GM in 10 ML (50 MG/ML) Injection
- RxCUI: 1667993 - 10 ML cysteine hydrochloride 50 MG/ML Injection
- RxCUI: 1667993 - cysteine HCl 0.5 GM per 10 ML Injection
- RxCUI: 2286589 - NOURESS 500 MG in 10 ML Injection
- RxCUI: 2286589 - 10 ML cysteine hydrochloride 50 MG/ML Injection [Nouress]
* Please review the full disclaimer at the bottom of this page.